Attached files
| file | filename |
|---|---|
| EX-10.48 - EXHIBIT 10.48 - Bellerophon Therapeutics, Inc. | t1602868_ex10-48.htm |
| EX-10.46 - EXHIBIT 10.46 - Bellerophon Therapeutics, Inc. | t1602868_ex10-46.htm |
| EX-5.1 - EXHIBIT 5.1 - Bellerophon Therapeutics, Inc. | t1602868_ex5-1.htm |
| EX-4.4 - EXHIBIT 4.4 - Bellerophon Therapeutics, Inc. | t1602868_ex4-4.htm |
| EX-3.3 - EXHIBIT 3.3 - Bellerophon Therapeutics, Inc. | t1602868_ex3-3.htm |
| S-1/A - AMENDMENT NO. 2 TO FORM S-1 - Bellerophon Therapeutics, Inc. | t1602868_s1a.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
The Board of Directors
Bellerophon Therapeutics, Inc.:
We consent to the use of our report incorporated by reference herein and to the reference to our firm under the heading "Experts" in the prospectus.
Short Hills, New Jersey
November 21, 2016